Showing results (161-170 of 201) with videos related to

Sort By:
Pageof 21
Haematologica|August 18, 2025
Two decades of single-institution data reveal rare long-term survivors of relapsed/refractory Burkitt lymphomaRabeya Molla, Kurt Bantilan, Ellin Berman, et al.
Blood Cancer Journal|May 22, 2019
Patterns of survival in patients with recurrent mantle cell lymphoma in the modern era: progressive shortening in response duration and survival after each relapseAnita Kumar, Fushen Sha, Ahmed Toure, et al.
Practical Radiation Oncology|August 25, 2024
Patterns of Locoregional Pancreatic Cancer Recurrence After Total Neoadjuvant Therapy and Implications on Optimal Neoadjuvant Radiation Treatment VolumesSara E Beltran Ponce, Christina J Small, Talha Ahmad, et al.
Cancer|August 7, 2025
Outpatient cytarabine consolidation in acute myeloid leukemia safely reduces hospitalization time and treatment costsHannah Burton, Leora Boussi, David Nemirovsky, et al.
Blood Advances|January 26, 2021
Active surveillance of primary extranodal marginal zone lymphoma of bronchus-associated lymphoid tissueErel Joffe, Yan Leyfman, Esther Drill, et al.
Blood Advances|October 1, 2020
T follicular helper phenotype predicts response to histone deacetylase inhibitors in relapsed/refractory peripheral T-cell lymphomaPaola Ghione, Promie Faruque, Neha Mehta-Shah, et al.
American Journal of Hematology|November 12, 2019
Incidence and outcomes of rare T cell lymphomas from the T Cell Project: hepatosplenic, enteropathy associated and peripheral gamma delta T cell lymphomasFrancine M Foss, Steven M Horwitz, Monica Civallero, et al.
Frontiers in Plant Science|March 6, 2015
Genomics-assisted breeding for boosting crop improvement in pigeonpea (Cajanus cajan)Lekha Pazhamala, Rachit K Saxena, Vikas K Singh, et al.
Blood Vessels, Thrombosis & Hemostasis|March 19, 2026
Intracranial hemorrhage in patients with primary brain cancer receiving anticoagulationEva N Hamulyák, Tzu-Fei Wang, Lisa Baumann Kreuziger, et al.
Blood|December 14, 2017
Activity of the PI3K-δ,γ inhibitor duvelisib in a phase 1 trial and preclinical models of T-cell lymphomaSteven M Horwitz, Raphael Koch, Pierluigi Porcu, et al.
Pageof 21